MY164112A - A combination composition comprising ibuprofen and paracetamol - Google Patents
A combination composition comprising ibuprofen and paracetamolInfo
- Publication number
- MY164112A MY164112A MYPI2012005317A MYPI2012005317A MY164112A MY 164112 A MY164112 A MY 164112A MY PI2012005317 A MYPI2012005317 A MY PI2012005317A MY PI2012005317 A MYPI2012005317 A MY PI2012005317A MY 164112 A MY164112 A MY 164112A
- Authority
- MY
- Malaysia
- Prior art keywords
- approximately
- paracetamol
- ibuprofen
- combination composition
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Abstract
A COMBINATION COMPOSITION FOR PROVIDING RELIEF FOR PAIN AND/OR INFLAMMATION, THE COMPOSITION HAVING IBUPROFEN AND PARACETAMOL AND BEING SUITABLE FOR USE IN DELIVERING TO A HUMAN INTRAVENOUSLY AT EACH DOSE: A) APPROXIMATELY 375 MG TO APPROXIMATELY 425 MG IBUPROFEN, IN COMBINATION WITH APPROXIMATELY 975 MG TO APPROXIMATELY 1,025 MG PARACETAMOL; OR B) APPROXIMATELY 175 MG TO APPROXIMATELY 225 MG IBUPROFEN, IN COMBINATION WITH APPROXIMATELY 475 MG TO APPROXIMATELY 525 MG PARACETAMOL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ58666110 | 2010-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY164112A true MY164112A (en) | 2017-11-30 |
Family
ID=45441395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2012005317A MY164112A (en) | 2010-07-07 | 2011-06-21 | A combination composition comprising ibuprofen and paracetamol |
Country Status (6)
Country | Link |
---|---|
AU (1) | AU2011274652B2 (en) |
MY (1) | MY164112A (en) |
NZ (1) | NZ604009A (en) |
SG (1) | SG186388A1 (en) |
WO (1) | WO2012005605A1 (en) |
ZA (1) | ZA201208210B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101900520B1 (en) | 2010-11-04 | 2018-09-19 | 에이에프티 파마슈티칼스 리미티드 | A combination composition |
CN103565733A (en) * | 2012-07-31 | 2014-02-12 | 南京帝易医药科技有限公司 | Ibuprofen sodium chloride injection preparation with pH of 6.0-6.5, and preparation method thereof |
US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
WO2023281089A2 (en) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising naproxen and paracetamol |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101022789A (en) * | 2004-07-07 | 2007-08-22 | Aft制药有限公司 | A combination composition |
US20090264530A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
-
2011
- 2011-06-21 SG SG2012093183A patent/SG186388A1/en unknown
- 2011-06-21 WO PCT/NZ2011/000117 patent/WO2012005605A1/en active Application Filing
- 2011-06-21 MY MYPI2012005317A patent/MY164112A/en unknown
- 2011-06-21 AU AU2011274652A patent/AU2011274652B2/en active Active
- 2011-06-21 NZ NZ60400911A patent/NZ604009A/en unknown
-
2012
- 2012-12-06 ZA ZA2012/08210A patent/ZA201208210B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2011274652B2 (en) | 2013-08-15 |
WO2012005605A1 (en) | 2012-01-12 |
NZ604009A (en) | 2015-03-27 |
ZA201208210B (en) | 2014-04-30 |
SG186388A1 (en) | 2013-01-30 |
AU2011274652A1 (en) | 2013-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12021550804A1 (en) | A combination composition | |
CA2683786C (en) | Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects | |
MX2013007189A (en) | Methods and compositions suitable for managing blood glucose in animals. | |
JP2011522896A5 (en) | ||
MX366090B (en) | Pharmaceutical combination for use in inducing weight loss in diabetes type 2 patients or/and for preventing weight gain in diabetes type 2 patients. | |
MX2012007933A (en) | Topical transdermal dexmedetomidine compositions and methods of use thereof. | |
MX2011007589A (en) | Treatment of a cancer using a combination of bendamustine and an anti-cd20 antibody. | |
EA201290833A1 (en) | APPLICATION OF AMISULPRIDE AS ANTI-TRAFFIC MEANS | |
AR089509A1 (en) | METHOD FOR TREATING LOSS OSEA ALVEOLAR, A DENTAL IMPLANT, AN ANTIBODYCEROSTIN ANTIBODY, A GEL OR MATRIX THAT INCLUDES SUCH ANTIBODY AND USE | |
MY164112A (en) | A combination composition comprising ibuprofen and paracetamol | |
MX340662B (en) | A medicinal product and treatment. | |
MX2009008108A (en) | Pharmaceutical composition comprising tramadol and ketoprofen. | |
WO2009012472A3 (en) | Methods and compositions for treating conditions | |
EP2566502A4 (en) | Methods for treating or preventing cardiovascular disorders and providing cardiovascular protection | |
MX2009008813A (en) | Pharmaceutical composition containing phloroglucinol and paracetamol. | |
TN2015000156A1 (en) | Dispersible tablet | |
WO2008091957A3 (en) | Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity | |
MX2015013911A (en) | Synergistic combination of paracetamol/celecoxib for the treatment of inflammatory pain. | |
HK1135030A1 (en) | Composition useful for the treatment of type 2 diabetes | |
CL2012003065A1 (en) | Pharmaceutical combination comprising ibuprofen and l-arginine in a weight ratio of ibuprofen / l-arginine between 1.6 and 5.6, with the exception of the value 1.97; solid pharmaceutical composition containing said combination; and its use in the treatment of pain, inflammation and / or fever. | |
HRPK20070344B3 (en) | Yoghurt with propolis and pollen | |
SA515360445B1 (en) | Dispersible tablet | |
UA29192U (en) | Adsorbing preparation with combined therapeutic action | |
UA101837C2 (en) | Injection agent with immunostimulant and systemic properties based on honey | |
MY154883A (en) | A combination composition |